July 12, 2013
2407 Mason Hall
Organizer contact: Marzena Żygis (firstname.lastname@example.org)
Click here for Workshop website.
Christine Mooshammer (USC, Los Angeles, email@example.com)
Stefanie Shattuck-Hufnagel (MIT, sshuf@MIT.EDU)
Marzena Żygis (Centre for General Linguistics (ZAS) & Humboldt University, Berlin, firstname.lastname@example.org)
Several studies on universals in phonology and phonetics pertain either to segmentals (e.g. sound frequencies, gaps in inventories, preferences for certain cluster types) or supra-segmentals (e.g. preferences in stress and intonational patterns). In recent years, accumulating evidence has suggested that language-specific interactions between the two levels can induce systematic temporal and qualitative variability on the segmental level. For example, most sounds lengthen substantially following a phrase boundary, but there are exceptions such as the sibilants; lax vowels do not lengthen under stress; and glottal stop insertion also depends on the quality of the following vowel. This workshop is aimed at gaining more insight into the interdependence of the segmental and prosodic levels from a cross-linguistic perspective. Papers which deal with the following questions are of particular importance:
(i) What patterns of segmental and supra-segmental interactions are found cross-linguistically?
(ii) How does metrical structure influence segments, phonotactics and phonological processes?
(iii) What principles govern segment-specific variation due to prosodic effects, e.g. localized hyper articulation, feature enhancement, syntagmatic dissimilation or prominence enhancement?
(iv) Why do some segments or larger units resist the more global prosodic variations, e.g. in order to maintain a contrast?
(v) How do different models deal with the segmental-prosodic variation, e.g. Exemplar Theory (Pierrehumbert 2001), pi-gesture model (Byrd & Saltzmann 2003), (bidirectional) OT (Boersma 1998) and others?
Laura Dilley, Michigan State University
Paul de Lacy, Rutgers University
Jelena Krivokapic, Haskins Labs